000788 北大医药
已收盘 08-16 15:00:00
资讯
新帖
简况
北大医药(000788)8月13日主力资金净卖出407.36万元
证券之星 · 08-13
北大医药(000788)8月13日主力资金净卖出407.36万元
北大医药:截止至2024年6月28日,公司股东总户数为51,617户
证券之星 · 07-25
北大医药:截止至2024年6月28日,公司股东总户数为51,617户
北大医药:感谢您的肯定和支持。系统性风险导致股价低迷,我们感同身受
证券之星 · 07-16
北大医药:感谢您的肯定和支持。系统性风险导致股价低迷,我们感同身受
北大医药:公司若触及相关重大事项,将严格按照相关监管法规要求及时履行信息披露义务
证券之星 · 07-15
北大医药:公司若触及相关重大事项,将严格按照相关监管法规要求及时履行信息披露义务
北大医药(000788.SZ)发预增,预计上半年净利润8300万元-9500万元 增长161.41%-199.21%
智通财经 · 07-12
北大医药(000788.SZ)发预增,预计上半年净利润8300万元-9500万元 增长161.41%-199.21%
【北大医药(000788.SZ)发预增,预计上半年净利润8300万元-9500万元 增长161.41%-199.21%】智通财经APP讯,北大医药(000788.
智通财经 · 07-12
【北大医药(000788.SZ)发预增,预计上半年净利润8300万元-9500万元 增长161.41%-199.21%】智通财经APP讯,北大医药(000788.
北大医药(000788.SZ):“盐酸左西替利嗪口服溶液”获得药品注册证书
智通财经 · 07-09
北大医药(000788.SZ):“盐酸左西替利嗪口服溶液”获得药品注册证书
【北大医药(000788.SZ):“盐酸左西替利嗪口服溶液”获得药品注册证书】智通财经APP讯,北大医药(000788.SZ)发布公告,公司收到国家药品监督管理局核准签发的《药品注册证书》,涉及药品:“盐酸左西替利嗪口服溶液”。
智通财经 · 07-09
【北大医药(000788.SZ):“盐酸左西替利嗪口服溶液”获得药品注册证书】智通财经APP讯,北大医药(000788.SZ)发布公告,公司收到国家药品监督管理局核准签发的《药品注册证书》,涉及药品:“盐酸左西替利嗪口服溶液”。
北大医药:公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务
证券之星 · 06-18
北大医药:公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务
内地税务服务机构:针对企业追缴税款属相关部门正常履职 营造公平营商环境
阿斯达克财经 · 06-18
内地税务服务机构:针对企业追缴税款属相关部门正常履职 营造公平营商环境
【多家上市公司被要求补税,专家:加强税收征管的一个缩影,“倒查30年”系误解】今年以来,多家A股上市公司遭遇补税,比如顺灏股份、北大医药、藏格矿业、华林证券、联建光电等。
智通财经 · 06-18
【多家上市公司被要求补税,专家:加强税收征管的一个缩影,“倒查30年”系误解】今年以来,多家A股上市公司遭遇补税,比如顺灏股份、北大医药、藏格矿业、华林证券、联建光电等。
北大医药:截止至2024年5月31日,公司股东总户数为52,312户
证券之星 · 06-17
北大医药:截止至2024年5月31日,公司股东总户数为52,312户
【“补税”风暴来袭最高4.8亿!多家A股公司被要求补缴税款】今年以来,多家A股上市公司遭遇“补税”问题,从博汇股份的停产公告到维维股份子公司多年前税款追缴,再到顺灏股份、北大医药、藏格矿业、华林证券等公司的补缴税款公告,这些公司最高补缴金额高达4.
智通财经 · 06-17
【“补税”风暴来袭最高4.8亿!多家A股公司被要求补缴税款】今年以来,多家A股上市公司遭遇“补税”问题,从博汇股份的停产公告到维维股份子公司多年前税款追缴,再到顺灏股份、北大医药、藏格矿业、华林证券等公司的补缴税款公告,这些公司最高补缴金额高达4.
北大医药:5月29日组织现场参观活动,投资者参与
证券之星 · 05-29
北大医药:5月29日组织现场参观活动,投资者参与
北大医药(000788)5月15日主力资金净卖出1760.69万元
证券之星 · 05-15
北大医药(000788)5月15日主力资金净卖出1760.69万元
北大医药(000788)5月7日主力资金净买入108.21万元
证券之星 · 05-07
北大医药(000788)5月7日主力资金净买入108.21万元
北大医药:截止至2024年4月30日,公司股东总户数为52,001户
证券之星 · 05-06
北大医药:截止至2024年4月30日,公司股东总户数为52,001户
5月3日北大医药涨停分析:新冠药物,医药,医药商业概念热股
证券之星 · 05-03
5月3日北大医药涨停分析:新冠药物,医药,医药商业概念热股
5月1日北大医药涨停分析:新冠药物,医药,医药商业概念热股
证券之星 · 05-01
5月1日北大医药涨停分析:新冠药物,医药,医药商业概念热股
4月30日北大医药涨停分析:新冠药物,医药,医药商业概念热股
证券之星 · 04-30
4月30日北大医药涨停分析:新冠药物,医药,医药商业概念热股
加载更多
公司概况
公司名称:
北大医药股份有限公司
所属行业:
医药制造业
上市日期:
1997-06-16
主营业务:
北大医药股份有限公司主要从事化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司主要产品为抗微生物、治疗精神障碍、调节血糖等。公司拥有国家级化学合成药物研发技术中心。2020年,公司医药工业凭借良好经营业绩及表现突出的品牌竞争力荣获“2020中国化学制药行业成长优秀企业品牌”、“2020中国化学制药行业两化融合推进优秀企业品牌”、“2020中国化学制药行业抗感染类优秀产品品牌”三项殊荣,上述奖项的获得也标志着业界对公司转型以来取得成绩的又一肯定。公司通过开展文化“重塑”与“融和”系列活动激活出企业发展新动能,并凭借良好成绩荣获由重庆市企业联合会(企业家协会)颁发的“2021~2022年度企业文化优秀成果”。
发行价格:
5.70
{"stockData":{"symbol":"000788","market":"SZ","secType":"STK","nameCN":"北大医药","latestPrice":5.63,"timestamp":1723791813000,"preClose":5.57,"halted":0,"volume":5123709,"delay":0,"floatShares":596000000,"shares":596000000,"eps":0.1204,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"08-16 15:00:00","open":5.59,"high":5.64,"low":5.52,"amount":28609800,"amplitude":0.0215,"askPrice":5.63,"askSize":132,"bidPrice":5.62,"bidSize":539,"shortable":0,"etf":0,"ttmEps":0.1204,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":5.57,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":6.13,"lowLimit":5.01,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":595987425,"pbRate":2.26,"roa":"--","roe":"3.05%","epsLYR":0.0744,"committee":-0.385833,"marketValue":3355000000,"floatMarketCap":3355000000,"peRate":46.760799,"changeRate":0.0108,"turnoverRate":0.0086,"status":0},"requestUrl":"/m/hq/s/000788","defaultTab":"news","newsList":[{"id":"2459942968","title":"北大医药(000788)8月13日主力资金净卖出407.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942968?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:25","pubTimestamp":1723533952,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月13日收盘,北大医药报收于5.62元,下跌1.06%,换手率1.03%,成交量6.16万手,成交额3449.03万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:北大医药2024年一季报显示,公司主营收入4.94亿元,同比下降0.95%;归母净利润4404.69万元,同比上升163.66%;扣非净利润4472.2万元,同比上升163.68%;负债率38.81%,财务费用-23.03万元,毛利率30.29%。北大医药主营业务:化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","000788","BK0096","BK0122","BK0060","BK0102","BK0028"],"gpt_icon":0},{"id":"2454841030","title":"北大医药:截止至2024年6月28日,公司股东总户数为51,617户","url":"https://stock-news.laohu8.com/highlight/detail?id=2454841030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454841030?lang=zh_cn&edition=full","pubTime":"2024-07-25 17:05","pubTimestamp":1721898316,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药07月25日在投资者关系平台上答复投资者关心的问题。投资者:请问截止7月19号收盘公司在册股东人数多少?截止至2024年6月28日,公司股东总户数为51,617户。关于当月股东数据,可至当月底问询。股东大会当天是正能量满满的一天,投票人数和代表股份数都创下了多年来的历史新高!立足当下,假以时日,相信公司股价会有溢价空间。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500036645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0012","BK0028","BK0096","BK0239","BK0102","BK0122","000788"],"gpt_icon":0},{"id":"2451961542","title":"北大医药:感谢您的肯定和支持。系统性风险导致股价低迷,我们感同身受","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451961542?lang=zh_cn&edition=full","pubTime":"2024-07-16 18:04","pubTimestamp":1721124261,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药07月16日在投资者关系平台上答复投资者关心的问题。感谢您的肯定和支持。系统性风险导致股价低迷,我们感同身受。相信持续好转的基本面是股价趋势向好的唯一保障。关心和支持公司基本面的好转是全体股东最大的利益所在,期待您积极参与公司治理,为股东大会积极投票,支持公司的发展,感谢您对北大医药的关注!本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600036464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0122","BK0239","BK0102","BK0060","BK0012","BK0028","BK0096"],"gpt_icon":0},{"id":"2451461933","title":"北大医药:公司若触及相关重大事项,将严格按照相关监管法规要求及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2451461933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451461933?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:04","pubTimestamp":1721034295,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药07月15日在投资者关系平台上答复投资者关心的问题。公司若触及相关重大事项,将严格按照相关监管法规要求及时履行信息披露义务,感谢您对北大医药的关注!此外,公司2024年半年度报告披露时间符合深交所相关监管法规的要求,公司已于2024年7月13日披露了《2024年半年度业绩预告》,感谢您对北大医药的关注!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500022893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0122","000788","BK0060","BK0239","BK0012","BK0102","BK0028"],"gpt_icon":0},{"id":"2450593307","title":"北大医药(000788.SZ)发预增,预计上半年净利润8300万元-9500万元 增长161.41%-199.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450593307","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450593307?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:13","pubTimestamp":1720779221,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北大医药(000788.SZ)发布2024年半年度业绩预告,预计上半年归属于上市公司股东的净利润8300万元-9500万元,同比增长161.41%-199.21%。上半年经营业绩同比增长,主要由于:1、医药工业板块重点产品收入结构变动,重点产品销量提升及降本增效带动盈利能力同比提升;2、医药流通板块中供应链管理业务收入规模同比提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000788"],"gpt_icon":0},{"id":"2450075273","title":"【北大医药(000788.SZ)发预增,预计上半年净利润8300万元-9500万元 增长161.41%-199.21%】智通财经APP讯,北大医药(000788.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450075273","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450075273?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:13","pubTimestamp":1720779221,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0060","BK0122","000788","BK0239","BK0012","BK0102","BK0028","BK0096"],"gpt_icon":0},{"id":"2450150890","title":"北大医药(000788.SZ):“盐酸左西替利嗪口服溶液”获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2450150890","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450150890?lang=zh_cn&edition=full","pubTime":"2024-07-09 17:35","pubTimestamp":1720517719,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北大医药(000788.SZ)发布公告,公司收到国家药品监督管理局核准签发的《药品注册证书》,涉及药品:“盐酸左西替利嗪口服溶液”。据悉,盐酸左西替利嗪是第二代H1受体拮抗剂,是抗组胺类治疗过敏性鼻炎和皮肤疾病的主要用药,与西替利嗪相比,左西替利嗪是其光学异构体,副作用更少。适应症包括荨麻疹、过敏性鼻炎、湿疹、皮炎、皮肤瘙痒症等。公告称,公司盐酸左西替利嗪口服溶液的获批不仅为公司研发工作再次积累了宝贵经验,更进一步完善了公司在抗过敏类领域的产品结构,有利于提升公司在抗过敏类治疗领域产品市场的竞争力,对公司未来业绩的提升有积极作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","000788","BK0102","BK0239","BK0122","BK0028","BK0060","BK0012"],"gpt_icon":0},{"id":"2450015706","title":"【北大医药(000788.SZ):“盐酸左西替利嗪口服溶液”获得药品注册证书】智通财经APP讯,北大医药(000788.SZ)发布公告,公司收到国家药品监督管理局核准签发的《药品注册证书》,涉及药品:“盐酸左西替利嗪口服溶液”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450015706","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450015706?lang=zh_cn&edition=full","pubTime":"2024-07-09 17:35","pubTimestamp":1720517719,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["000788","BK0102","BK0122","BK0028","BK0096","BK0060","BK0012","BK0239"],"gpt_icon":0},{"id":"2444567109","title":"北大医药:公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2444567109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444567109?lang=zh_cn&edition=full","pubTime":"2024-06-18 17:04","pubTimestamp":1718701449,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药06月18日在投资者关系平台上答复投资者关心的问题。合成药物研究所成立多久了?公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务。公司技术中心设立有合成部,自研项目以小分子化学药品合成为主,感谢您对北大医药的关注!本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061800033228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0060","159938","09939","000788","BK0028","BK0102","BK1574","BK1161","BK1515","BK0239","BK0122","BK0096"],"gpt_icon":0},{"id":"2444178648","title":"内地税务服务机构:针对企业追缴税款属相关部门正常履职 营造公平营商环境","url":"https://stock-news.laohu8.com/highlight/detail?id=2444178648","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444178648?lang=zh_cn&edition=full","pubTime":"2024-06-18 13:01","pubTimestamp":1718686860,"startTime":"0","endTime":"0","summary":"据《澎湃新闻》从相关权威涉税服务机构处获悉,去年以来,有关部门加大对税务系统应收尽收的监督力度,当前针对个别企业的追缴税款是税务等相关部门正常履职,也是对足额缴纳税款企业的保护,营造公平公正的税收营商环境。报道引述业内专家认为,近年来,税务部门以“零容忍”的态度依法严肃查处涉税违法行为,不仅是对违法者的一种警示,也是为守法者营造公平公正的税收秩序,有利于推动相关行业规范健康发展。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20200521223737080_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20200521223737080_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1357245/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["300839","BK0098","BK0012","BK0276","BK0229","BK0070","BK0201","BK0275","BK0141","BK0197","300269","BK0060","000408","BK0222","BK0239","000788","BK0096","SGXZ81163826.USD","BK0188","BK0102","BK0182","600300","BK0186","BK0210","BK0122","BK0155","BK0215","002945","002565","BK0196","BK0028","SGXZ49509284.SGD","BK0127"],"gpt_icon":0},{"id":"2444214926","title":"【多家上市公司被要求补税,专家:加强税收征管的一个缩影,“倒查30年”系误解】今年以来,多家A股上市公司遭遇补税,比如顺灏股份、北大医药、藏格矿业、华林证券、联建光电等。","url":"https://stock-news.laohu8.com/highlight/detail?id=2444214926","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444214926?lang=zh_cn&edition=full","pubTime":"2024-06-18 08:21","pubTimestamp":1718670108,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0222","002945","BK0012","BK0141","BK0102","BK0096","159982","BK0155","BK0098","BK0182","000408","SGXZ81163826.USD","BK0239","SGXZ49509284.SGD","BK0276","300269","BK0197","399300","000788","BK0229","BK0196","BK0186","BK0070","BK0122","002565","BK0028","BK0060","BK0127","BK0210"],"gpt_icon":0},{"id":"2444152501","title":"北大医药:截止至2024年5月31日,公司股东总户数为52,312户","url":"https://stock-news.laohu8.com/highlight/detail?id=2444152501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444152501?lang=zh_cn&edition=full","pubTime":"2024-06-17 18:04","pubTimestamp":1718618686,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药06月17日在投资者关系平台上答复投资者关心的问题。截止至2024年5月31日,公司股东总户数为52,312户,感谢您对北大医药的关注!投资者:请问截止5月31日股东户数北大医药董秘:投资者您好!本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061700022404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0122","BK0028","BK0096","BK0060","BK0239","BK0012","000788"],"gpt_icon":0},{"id":"2444681131","title":"【“补税”风暴来袭最高4.8亿!多家A股公司被要求补缴税款】今年以来,多家A股上市公司遭遇“补税”问题,从博汇股份的停产公告到维维股份子公司多年前税款追缴,再到顺灏股份、北大医药、藏格矿业、华林证券等公司的补缴税款公告,这些公司最高补缴金额高达4.","url":"https://stock-news.laohu8.com/highlight/detail?id=2444681131","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444681131?lang=zh_cn&edition=full","pubTime":"2024-06-17 14:43","pubTimestamp":1718606632,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159982","BK0155","SGXZ81163826.USD","600300","BK0222","BK0127","SGXZ49509284.SGD","BK0276","BK0215","000788","BK0188","BK0102","BK0201","BK0012","BK0229","002565","BK0060","399300","002945","BK0275","BK0196","BK0028","BK0096","BK0122","BK0239","BK0182","000408","300839"],"gpt_icon":0},{"id":"2439529644","title":"北大医药:5月29日组织现场参观活动,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2439529644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439529644?lang=zh_cn&edition=full","pubTime":"2024-05-29 20:31","pubTimestamp":1716985894,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年5月29日北大医药发布公告称公司于2024年5月29日组织现场参观活动。北大医药主营业务:化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。北大医药2024年一季报显示,公司主营收入4.94亿元,同比下降0.95%;归母净利润4404.69万元,同比上升163.66%;扣非净利润4472.2万元,同比上升163.68%;负债率38.81%,财务费用-23.03万元,毛利率30.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052900040651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","000788","BK0012","BK0122","BK0102","BK0096","BK0060"],"gpt_icon":0},{"id":"2435688412","title":"北大医药(000788)5月15日主力资金净卖出1760.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435688412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435688412?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:28","pubTimestamp":1715758131,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月15日收盘,北大医药报收于5.76元,下跌2.7%,换手率2.3%,成交量13.71万手,成交额7995.95万元。5月15日的资金流向数据方面,主力资金净流出1760.69万元,占总成交额22.02%,游资资金净流出1100.54万元,占总成交额13.76%,散户资金净流入2861.23万元,占总成交额35.78%。北大医药主营业务:化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500022537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","000788","BK0096","BK0122","BK0060","BK0102","BK0028"],"gpt_icon":0},{"id":"2433882241","title":"北大医药(000788)5月7日主力资金净买入108.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433882241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433882241?lang=zh_cn&edition=full","pubTime":"2024-05-07 15:26","pubTimestamp":1715066768,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月7日收盘,北大医药报收于6.0元,下跌1.8%,换手率5.36%,成交量31.93万手,成交额1.92亿元。5月7日的资金流向数据方面,主力资金净流入108.21万元,占总成交额0.56%,游资资金净流出852.29万元,占总成交额4.45%,散户资金净流入744.08万元,占总成交额3.88%。北大医药主营业务:化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700019881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0122","BK0028","000788","BK0060","BK0102","BK0239","BK0096"],"gpt_icon":0},{"id":"2433426854","title":"北大医药:截止至2024年4月30日,公司股东总户数为52,001户","url":"https://stock-news.laohu8.com/highlight/detail?id=2433426854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433426854?lang=zh_cn&edition=full","pubTime":"2024-05-06 19:03","pubTimestamp":1714993400,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药05月06日在投资者关系平台上答复投资者关心的问题。投资者:请部截止2024年3月20日收盘公司股东人数是多少?投资者:请问截止到3月31日股东户数北大医药董秘:投资者您好!截止至2024年4月30日,公司股东总户数为52,001户,感谢您对北大医药的关注!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600021579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","000788","BK0012","BK0122","BK0102","BK0096","BK0060"],"gpt_icon":0},{"id":"2432949696","title":"5月3日北大医药涨停分析:新冠药物,医药,医药商业概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432949696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432949696?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:10","pubTimestamp":1714720254,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药涨停收盘,收盘价5.91元。该股于13点39分涨停,未打开涨停,截止收盘封单资金为3434.6万元,占其流通市值0.98%。该股为新冠药物,医药,医药商业概念热股,当日新冠药物概念上涨2.06%,医药概念上涨1.17%,医药商业概念上涨1.03%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050300003246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0122","000788","BK1515","09939","BK0060","BK1574","BK0239","BK0012","BK1161","159938","BK0102","BK0028"],"gpt_icon":0},{"id":"2432299510","title":"5月1日北大医药涨停分析:新冠药物,医药,医药商业概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432299510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432299510?lang=zh_cn&edition=full","pubTime":"2024-05-01 15:12","pubTimestamp":1714547550,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药涨停收盘,收盘价5.91元。该股于13点39分涨停,未打开涨停,截止收盘封单资金为3434.6万元,占其流通市值0.98%。该股为新冠药物,医药,医药商业概念热股,当日新冠药物概念上涨2.06%,医药概念上涨1.17%,医药商业概念上涨1.03%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050100017268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","159938","BK0028","BK1574","BK1515","BK0096","BK0122","BK0239","BK0060","000788","BK0102","BK1161","BK0012"],"gpt_icon":0},{"id":"2431361299","title":"4月30日北大医药涨停分析:新冠药物,医药,医药商业概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431361299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431361299?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:39","pubTimestamp":1714462754,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药涨停收盘,收盘价5.91元。该股于13点39分涨停,未打开涨停,截止收盘封单资金为3434.6万元,占其流通市值0.98%。4月30日的资金流向数据方面,主力资金净流入3166.59万元,占总成交额19.24%,游资资金净流出1572.0万元,占总成交额9.55%,散户资金净流出1594.58万元,占总成交额9.69%。近5日资金流向一览见下表:该股为新冠药物,医药,医药商业概念热股,当日新冠药物概念上涨2.06%,医药概念上涨1.17%,医药商业概念上涨1.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000028125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0122","BK0028","BK0096","BK1515","BK0060","BK1574","BK1161","159938","BK0239","09939","000788","BK0012"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-06-16","address":"重庆市北碚区水土镇方正大道21号","stockEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.0806},{"period":"3month","weight":-0.0313},{"period":"6month","weight":0.2325},{"period":"1year","weight":-0.1824},{"period":"ytd","weight":-0.1568}],"companyName":"北大医药股份有限公司","boardCode":"AI0027","perCapita":"11546股","boardName":"医药制造业","registeredCapital":"59598万元","compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"survey":" 北大医药股份有限公司主要从事化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司主要产品为抗微生物、治疗精神障碍、调节血糖等。公司拥有国家级化学合成药物研发技术中心。2020年,公司医药工业凭借良好经营业绩及表现突出的品牌竞争力荣获“2020中国化学制药行业成长优秀企业品牌”、“2020中国化学制药行业两化融合推进优秀企业品牌”、“2020中国化学制药行业抗感染类优秀产品品牌”三项殊荣,上述奖项的获得也标志着业界对公司转型以来取得成绩的又一肯定。公司通过开展文化“重塑”与“融和”系列活动激活出企业发展新动能,并凭借良好成绩荣获由重庆市企业联合会(企业家协会)颁发的“2021~2022年度企业文化优秀成果”。","serverTime":1723944587807,"listedPrice":5.7,"stockholders":"51617人(较上一季度减少1.33%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北大医药,000788,北大医药股票,北大医药股票老虎,北大医药股票老虎国际,北大医药行情,北大医药股票行情,北大医药股价,北大医药股市,北大医药股票价格,北大医药股票交易,北大医药股票购买,北大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}